DMW-65172-85268
3 vaccinations
3 coded responses
17 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 454 / OH
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-26
-
2021-02-02
Dose 2 — Pfizer-BioNTech
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-16
-
2022-01-04
Dose 3 — Pfizer-BioNTech
-
2022-01-05
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain, Respiratory tract congestion, Sinus pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat sinus pain and congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain, Paranasal sinus discomfort — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat sinus pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-09
- 2022-01-10
-
2022-02-03
Survey response — day 28, dose 3MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid +MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2022-01-04 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat sinus pain and congestion
Systemic reaction (other): Sore throat sinus pressure
Release 11 — day 28, dose 3
Symptoms: Covid +
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Paranasal sinus discomfort | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Sinus pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release